Neuraxis, Inc. Files 8-K on Financials

Ticker: NRXS · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1933567

Neuraxis, INC 8-K Filing Summary
FieldDetail
CompanyNeuraxis, INC (NRXS)
Form Type8-K
Filed DateJan 8, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, sec-filing

TL;DR

Neuraxis filed an 8-K on Jan 8, 2025, updating its financial condition. Check it out.

AI Summary

Neuraxis, Inc. filed an 8-K on January 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Carmel, Indiana.

Why It Matters

This filing provides an update on Neuraxis, Inc.'s financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediately alarming or significant new information.

Key Numbers

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported was on January 8, 2025.

Where are Neuraxis, Inc.'s principal executive offices located?

The principal executive offices are located at 11611 N. Meridian St, Suite 330, Carmel, IN 46032.

In which state was Neuraxis, Inc. incorporated?

Neuraxis, Inc. was incorporated in Delaware.

What is the company's SEC file number?

The SEC file number for Neuraxis, Inc. is 001-41775.

Filing Stats: 621 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-01-08 09:21:59

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 8, 2025 NEURAXIS, INC. By: /s/ Brian Carrico Name: Brian Carrico Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing